PMID- 35365118 OWN - NLM STAT- MEDLINE DCOM- 20220405 LR - 20220405 IS - 1471-2415 (Electronic) IS - 1471-2415 (Linking) VI - 22 IP - 1 DP - 2022 Apr 1 TI - Thickness measurements taken with the spectralis OCT increase with decreasing signal strength. PG - 148 LID - 10.1186/s12886-022-02356-4 [doi] LID - 148 AB - BACKGROUND: Optical coherence tomography (OCT) is used worldwide by clinicians to evaluate macular and retinal nerve fiber layer (RNFL) characteristics. It is frequently utilized to assess disease severity, progression and efficacy of treatment, and therefore must be reliable and reproducible. OBJECTIVE: To examine the influence of signal strength on macular thickness parameters, macular volume measurement and RNFL thickness measured by spectral-domain optical coherence tomography (SD-OCT). METHODS: Macular thickness parameters, macular volume measurement and RNFL thickness were measured by the Spectralis(R) OCT (Heidelberg Engineering, Heidelberg, Germany). In each eye, the focusing knob was adjusted to obtain 4 images with different signal strengths - Low (below 15), Moderate (15-20), Good (20-25) and Excellent (above 25). The relationship between signal strength and measured data was assessed using the mixed model procedure. RESULTS: A total of 71 eyes of 41 healthy subjects were included. Central macular thickness, macular volume and mean RNFL thickness increased with decreasing signal strength. Specifically, eyes with excellent signal strength showed significantly thinner central macular thickness (p = 0.023), macular volume (p = 0.047), and mean RNFL thickness (p = 0.0139). CONCLUSIONS: Higher signal strength is associated with lower macular thickness, macular volume and RNFL thickness measurements. The mean differences between excellent and low-quality measurements were small implicating that SD-OCT is a reliable imaging tool even at low quality scans. It is imperative that the physician compares the signal strength of all scans, as minute differences may alter results. CI - (c) 2022. The Author(s). FAU - Gershoni, Assaf AU - Gershoni A AD - Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel. AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. FAU - Barayev, Edward AU - Barayev E AD - Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel. AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. FAU - Vainer, Igor AU - Vainer I AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. AD - Department of Otolaryngology, Rabin Medical Center, Petah Tikva, Israel. FAU - Allon, Raviv AU - Allon R AD - Department of Otolaryngology, Kaplan Medical Center, Rehovot, Israel. FAU - Yavnieli, Roy AU - Yavnieli R AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. AD - Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel. FAU - Shapira, Yinon AU - Shapira Y AD - Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel. FAU - Mimouni, Michael AU - Mimouni M AD - Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel. FAU - Geffen, Noa AU - Geffen N AD - Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel. AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. FAU - Nemet, Arie Yehuda AU - Nemet AY AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. AD - Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel. FAU - Segal, Ori AU - Segal O AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. orisegal@gmail.com. AD - Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel. orisegal@gmail.com. LA - eng PT - Journal Article DEP - 20220401 PL - England TA - BMC Ophthalmol JT - BMC ophthalmology JID - 100967802 SB - IM MH - Humans MH - Nerve Fibers MH - *Optic Disk MH - Retina/diagnostic imaging MH - Retinal Ganglion Cells MH - *Tomography, Optical Coherence/methods PMC - PMC8976355 OTO - NOTNLM OT - Macular thickness OT - Optical Coherence tomography OT - Retinal nerve fiber layer OT - Signal strength OT - Spectralis COIS- All authors declare no conflict of interest. EDAT- 2022/04/03 06:00 MHDA- 2022/04/06 06:00 PMCR- 2022/04/01 CRDT- 2022/04/02 05:21 PHST- 2021/05/29 00:00 [received] PHST- 2021/10/07 00:00 [accepted] PHST- 2022/04/02 05:21 [entrez] PHST- 2022/04/03 06:00 [pubmed] PHST- 2022/04/06 06:00 [medline] PHST- 2022/04/01 00:00 [pmc-release] AID - 10.1186/s12886-022-02356-4 [pii] AID - 2356 [pii] AID - 10.1186/s12886-022-02356-4 [doi] PST - epublish SO - BMC Ophthalmol. 2022 Apr 1;22(1):148. doi: 10.1186/s12886-022-02356-4.